Home › Compound Library › GLP-1 & Metabolic › Liraglutide
GLP-1 & Metabolic Research High Evidence

Liraglutide

First-generation GLP-1 receptor agonist (Victoza/Saxenda). Once-daily injectable studied extensively for T2D glycemic control and obesity. Foundational molecule in the GLP-1 research class.

GLP-1weight lossdiabetesT2Dcardiovascularobesityincretin
Half-life
~13 hours; allows once-daily dosing
SKUs Available
2
Evidence Level
High Evidence
Mechanism of Action

GLP-1 receptor agonist with 97% sequence homology to native GLP-1, extended by albumin binding fatty acid side chain. Stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, reduces appetite via central hypothalamic pathways.

Published Research Ranges & Study Context

Studies have administered: 0.6–1.8mg/day for T2D research; 3.0mg/day for obesity endpoint studies (SCALE trials)

Important Research Framing These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings

LEADER trial: 13% CV death reduction in high-risk T2D. SCALE trial: ~8% weight loss vs placebo. Significant HbA1c reduction across multiple trials. Established CV and renal protective signals.

High Evidence Multiple large human RCTs available
Side Effects Observed in Research

GI: nausea (most common), vomiting, diarrhea especially at initiation; injection site reactions; rare pancreatitis signal in animal models

Available Configurations (SKU Reference)
LIR6 LIR18
Compounds Studied in Combination

These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.

Want a Complete Research Monograph?

Our AI can generate a 2,000+ word deep-dive on Liraglutide — including full clinical trial summaries, pharmacokinetics, and research frontiers.

Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.